AMERICAN REGENT

VASOPRESSIN (AMERICAN REGENT)

Manufacturer:

AMERICAN REGENT

Vasopressin (American Regent) HCPCS:

J2599

HCPCS Code Descriptor:

Injection, vasopressin (american regent) not therapeutically equivalent to j2598, 1 unit

Category:

J Code

Vasopressin (American Regent) NDCs:

00517-1020-25, 00517-1030-01

Primary Type:

Hormone Replacement

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00517-1020-25

About Vasopressin (American Regent):

VASOPRESSIN (AMERICAN REGENT) is a Hormone Replacement drug manufactured by AMERICAN REGENT and administered via the Intravenous route of administration. The J Code: J2599 is aligned to the drug VASOPRESSIN (AMERICAN REGENT) .

ACCESS PRICING AND MORE BY REGISTERING

J2599 Added Date:

July 1, 2023

J2599 Effective Date:

July 1, 2023

J2599 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Vasopressin (American Regent) billing and coding information.
Our team did not identify a source for Vasopressin (American Regent) patient assistance information. Please reach out to our team if you feel that this is a mistake.
VASOPRESSIN (AMERICAN REGENT) prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for VASOPRESSIN (AMERICAN REGENT). Please check back in a few weeks.